Oppenheimer raised the firm’s price target on Ligand (LGND) to $151 from $135 and keeps an Outperform rating on the shares following the company’s investor day. Key takeaways, the firm says ...

The Discovery of New Members of the TNF Receptor and Ligand Families and Their Relationship to Osteoclasts and Bone Metabolism Binding of RANKL to RANK initiates a signaling cascade, which ...

P2Rank: Protein-ligand binding site prediction from protein structure based on machine learning.

In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...

Discover how stress worsens skin allergies by disrupting immune responses and the role of caspase-1 inhibitors in managing ...

This publication is Open Access under the license indicated. Learn More ...

It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the ...

Golfers at the Atlantic Beach Links, situated 700m from the beach in Melkbosstrand, Cape Town, were treated to a spectacular ...

Spatial transcriptomics was combined with single-nucleus RNA sequencing to annotate healthy and fibrotic human livers, improving spatial resolution of hepatocytes and receptor-ligand interactions ...

Transaction Expands Climb Bio’s Pipeline of B-cell Targeted Therapeutics to Address Immune-mediated Diseases New Program is a ...

Eliem Therapeutics is continuing its transformation into an immune-mediated disease company by paying $9 million to ...